| 5 |
Rennke HG. Secondary membranoproliferative glomerulonephritis[J]. Kidney Int,1995,47(2):643-656.
|
| 6 |
Walker PD, Ferrario F, Joh K, et al. Dense deposit disease is not a membranoproliferative glomerulonephritis [J]. Mod Pathol, 2007,20(6):605-616.
|
| 7 |
李云生,陈楠. 膜增殖性肾炎的临床病理分析及预后因素探讨[J].中国中西医结合肾病杂志,2006,7(1):30.
|
| 8 |
俞雨生,陈慧萍,刘红,等. 原发性膜增生性肾炎的远期预后及影响因素分析[J].肾脏病与透析肾移植杂志,2002,11(3):218.
|
| 9 |
Takei T, Itabashi M, Moriyama T,et al. Positive C1q staining associated with poor renal outcome in membranoproliferative glomerulonephritis [J]. Clin Exp Nephrol,2013,17(1):92-98.
|
| 10 |
Ford DM, Briscoe DM, Shanley PF, et al. Childhood membranoproliferative glomerulonephritis type I: limited steroid therapy [J]. Kidney Int,1992,41(6):1606-1612.
|
| 11 |
Yanagihara T, Hayakawa M, Yoshida J, et al. Long term follow-up of diffuse membranoproliferative glomerulonephritis type I [J].Pediatr Nephrol,2005,20(5):585-590.
|
| 12 |
Kidney Disease: Improving Global Outcomes (KDIGO)Glomerulonephritis Work Group. KDIGO clinical practice guideline for glomerulonephritis [J]. Kidney Int Suppl, 2012, 2(2): 139-274.
|
| 13 |
陈德政,戎殳,李林,等. 41 例成人原发性膜增殖性肾炎的临床与病理分析[J].中国中西医结合肾病杂志,2008,9(2):140.
|
| 14 |
Brenner BM. The Kidney [M]. 7th ed. Philadelphia: Saunders WB,2001:1324-1326.
|
| 1 |
邹万忠. 肾活检病理学[M]. 北京:北京大学医学出版社,2009:80-85;142-143.
|
| 2 |
章友康,王素霞. 超微病理在肾脏疾病诊断中的作用及其评价[J].诊断学理论与实践,2007,6(6):505.
|
| 3 |
王海燕主编. 肾脏病学[M]. 北京:人民卫生出版社, 2008:598-614,676-679.
|
| 4 |
叶任高,李幼姬,刘冠贤主编. 临床肾脏病学[M]. 北京:人民卫生出版社,2008:168.
|